Examining the relationship between symptoms watched in lung cancer patients and illness perception

dc.contributor.authorUgur O.
dc.contributor.authorKaradag E.
dc.contributor.authorMert H.
dc.contributor.authorSahin C.K.
dc.contributor.authorGurel T.Y.
dc.contributor.authorKarakus H.S.
dc.date.accessioned2024-07-22T08:04:27Z
dc.date.available2024-07-22T08:04:27Z
dc.date.issued2022
dc.description.abstractObjective: To examine the relationship between the symptom experience of lung cancer patients and their illness perception of the disease. Methods: The descriptive and cross-sectional study was conducted from April to September 2015 at the Chemotherapy Treatment Centre of the Medicine Chest Diseases Clinic at the Ege University, Izmir, Turkey, and comprised lung cancer patients of either gender aged >18 years. Data was collected using a predesigned Patient Questionnaire as well as the standard Lung Cancer Symptom Scale, Illness Perception Questionnaire and Karnofsky Performance Scale. The patients' sociodemographic characteristics and data on their illness, the symptoms they experienced and the numerical and percentage distribution of the items on the illness perception scale, mean and standard deviation values were examined. Pearson Correlation analysis was used to examine the correlation between illness perception and Karnofsky Performance Scale scores and other variables. Results: Of the 105 patients, 86(81.9%) were males, 86(81.9%) were married, 49(46.7%) were elementary school graduates, 101(96.2%) were unemployed, and 95(90.5%) were receiving chemotherapy. The overall mean age of the sample was 61.43±8.24 years, the period since diagnosis was 11.38±17.84 months, and the duration of chemotherapy was 4.28±2.37 months. The mean symptom burden score was 22.75±10.85 and the Lung Cancer Symptom Scale score was 22.75±10.85. The mean score of the type of illness domain was 5.53±2.12. The overall mean global quality of life score was 64.30±12.60. Conclusions: As the symptom burden experienced by the lung cancer patients increased, their perception of the illness became more negative, and the longer the cyclical periods and the period of diagnosis, the patients' control over their illness decreased. © 2022 Pakistan Medical Association. All rights reserved.
dc.identifier.DOI-ID10.47391/JPMA.0179
dc.identifier.issn00309982
dc.identifier.urihttp://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12700
dc.language.isoEnglish
dc.publisherPakistan Medical Association
dc.rightsAll Open Access; Gold Open Access
dc.subjectAged
dc.subjectCross-Sectional Studies
dc.subjectFemale
dc.subjectHumans
dc.subjectLung Neoplasms
dc.subjectMale
dc.subjectMiddle Aged
dc.subjectPerception
dc.subjectQuality of Life
dc.subjectSurveys and Questionnaires
dc.subjectadult
dc.subjectArticle
dc.subjectcancer chemotherapy
dc.subjectcancer patient
dc.subjectcoughing
dc.subjectcross-sectional study
dc.subjectdyspnea
dc.subjecteducation
dc.subjectfatigue
dc.subjectfemale
dc.subjecthealth insurance
dc.subjecthemoptysis
dc.subjectIllness Perception Questionnaire
dc.subjectinterview
dc.subjectKarnofsky Performance Status
dc.subjectLikert scale
dc.subjectloss of appetite
dc.subjectlung cancer
dc.subjectlung cancer symptom scale
dc.subjectmale
dc.subjectmiddle aged
dc.subjectpain
dc.subjectperception
dc.subjectphysiological stress
dc.subjectquality of life
dc.subjectrisk factor
dc.subjectscoring system
dc.subjectsmoking
dc.subjectsymptom
dc.subjectvisual analog scale
dc.subjectaged
dc.subjectcomplication
dc.subjecthuman
dc.subjectlung tumor
dc.subjectperception
dc.subjectquality of life
dc.subjectquestionnaire
dc.titleExamining the relationship between symptoms watched in lung cancer patients and illness perception
dc.typeArticle

Files